PPARα augments heart function and cardiac fatty acid oxidation in early experimental polymicrobial sepsis

Stephen W Standage1,2, Brock G Bennion3,2, Taft O Knowles3,2

  • 1Center for Lung Biology, University of Washington School of Medicine, Seattle, Washington; sws24@uw.edu.

Insights

Peroxisome proliferator-activated receptor-α (PPARα) supports early heart function during sepsis by increasing fatty acid oxidation. Its absence impairs cardiac performance and survival in mouse sepsis models.

Area of Science:

  • Cardiovascular Physiology
  • Metabolic Regulation
  • Sepsis Pathophysiology

Background:

  • Sepsis is linked to downregulated peroxisome proliferator-activated receptor-α (PPARα) in children.
  • PPARα deficiency in mouse models correlates with reduced survival and cardiac injury during sepsis.

Purpose of the Study:

  • To investigate the role of PPARα in cardiac function during early sepsis.
  • To determine if PPARα influences cardiac fatty acid metabolism in sepsis.

Main Methods:

  • Utilized a clinically relevant mouse model of early sepsis.
  • Assessed cardiac function using echocardiography and ex vivo working heart studies.
  • Measured cardiac fatty acid oxidation and citric acid cycle enzyme regulation.

Main Results:

  • Wild-type mice showed increased heart function within 24 hours of sepsis, unlike PPARα-deficient mice.
  • PPARα-deficient mice exhibited reduced cardiac performance and impaired fatty acid oxidation.
  • Cardiac fatty acid oxidation was elevated in wild-type but not PPARα-deficient mice during sepsis.

Conclusions:

  • PPARα expression is crucial for supporting the hyperdynamic cardiac response in early sepsis.
  • Enhanced cardiac fatty acid oxidation, regulated by PPARα, may mitigate sepsis-induced morbidity and mortality.

Related Concept Videos